SHPHShuttle Pharmaceuticals Holdings, Inc.
Earnings
When Shuttle Pharmaceuticals Holdings, Inc. reports, what it reported each quarter, and how the stock took the results.
22 quarters. Mar 31, 2021 to Jun 30, 2026. mixed units.
Next results · Q3 2026Running late
Tuesday, after the close
Tue, Nov 24, 2026in 6 days
Its usual day, Nov 17, 2026, passed with no release on file.
- Quarter
- Q3 2026 · Ended Sep 30, 2026
- 10-Q window
- Nov 9 – Dec 8
Read against Q3 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- —
- Net income
- -$2.35M
- Net income, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m, Q3 2025 n/m
- EPS
- -$1.05
- EPS, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m, Q2 2025 n/m
Latest results
- Revenue
- —
- —
- Net income
- -$3.15M
- N/M
- EPS
- -$3.10
- N/M
- Revenue
- —
- —
- Net income
- -$2.15M
- N/M
- EPS
- -$0.43
- N/M
- Revenue
- —
- —
- Net income
- -$2.61M
- N/M
- EPS
- —
- —
- Revenue
- —
- —
- Net income
- -$2.35M
- N/M
- EPS
- -$1.05
- N/M
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q2 2026 | Jun 30, 2026 | — | Sep 24, 2026 | 86 d | 10-Q | — | — | -$3.10 | +6.4% | |
| Q1 2026 | Mar 31, 2026 | — | May 15, 2026 | 45 d | 10-Q | — | — | -$0.43 | 7.8% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Feb 17, 2026 · after-hours | Mar 31, 2026 | 90 d | 10-K | — | — | — | +7.4% | |
| Q3 2025 | Sep 30, 2025 | — | Nov 13, 2025 | 44 d | 10-Q | — | — | -$1.05 | 8.0% | |
| Q2 2025 | Jun 30, 2025 | — | Aug 13, 2025 | 44 d | 10-Q | — | — | -$32.91 | 2.5% | |
| Q1 2025 | Mar 31, 2025 | — | May 8, 2025 | 38 d | 10-Q | — | — | -$7.60 | 14.8% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | Feb 26, 2025 · market hours | Feb 26, 2025 | 57 d | 10-K | — | — | — | +2.7% | |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 · after-hours | Nov 13, 2024 | 44 d | 10-Q | — | — | -$39.83 | 0.9% | |
| Q2 2024 | Jun 30, 2024 | — | Sep 4, 2024 | 66 d | 10-Q | — | — | -$24.12 | +12.9% | |
| Q1 2024 | Mar 31, 2024 | — | May 13, 2024 | 43 d | 10-Q | — | — | -$0.83 | +2.4% | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | — | Mar 21, 2024 | 81 d | 10-K | — | — | — | 6.5% | |
| Q3 2023 | Sep 30, 2023 | — | Nov 13, 2023 | 44 d | 10-Q | — | — | -$0.91 | — | |
| Q2 2023 | Jun 30, 2023 | — | Aug 14, 2023 | 45 d | 10-Q | — | — | -$1.23 | — | |
| Q1 2023 | Mar 31, 2023 | — | May 25, 2023 | 55 d | 10-Q | — | — | -$0.57 | +0.8% | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 15, 2023 | 74 d | 10-K | — | — | — | +4.3% | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | — | — | -$0.10 | +5.3% | |
| Q2 2022 | Jun 30, 2022 | — | — | — | — | — | — | -$0.06 | — | |
| Q1 2022 | Mar 31, 2022 | — | — | — | — | — | — | — | — | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | — | — | — | — | — | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | — | — | — | — | — | — | — | |
| Q2 2021 | Jun 30, 2021 | — | — | — | — | — | — | — | — | |
| Q1 2021 | Mar 31, 2021 | — | — | — | — | — | — | — | — | |
Earlier years, FY 2021 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Shuttle Pharmaceuticals Holdings, Inc. · CIK 1757499 · Engraved from SEC EDGAR